About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 969476, 8 pages
Research Article

Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic

National Hematological Medical Center of Traditional Chinese Medicine, Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China

Received 30 July 2012; Revised 3 September 2012; Accepted 10 September 2012

Academic Editor: Shao Li

Copyright © 2012 Sun Shuzhen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Rou Ma, “Treating exploration and prospect on myelodysplastic syndromes,” Journal of Leukemia and Lymphoma, vol. 22, no. 2, pp. 85–87, 2013. View at Publisher · View at Google Scholar
  • Xiao-Mei Hu, Bo Yuan, Sachiko Tanaka, Min-Min Song, Kenji Onda, Kaoru Tohyama, Ai-Xiang Zhou, Hiroo Toyoda, and Toshihiko Hirano, “Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines,” Hematology, vol. 19, no. 6, pp. 352–360, 2014. View at Publisher · View at Google Scholar
  • Xue-qing Hu, and Shi-bing Su, “An overview of epigenetics in Chinese medicine researches,” Chinese Journal of Integrative Medicine, 2016. View at Publisher · View at Google Scholar